# Contrast-Enhanced Ultrasound Scan for the Estimation of Tissue Pressure in Patients With Breast Cancer

> **NCT04721886** · EARLY_PHASE1 · COMPLETED · sponsor: **Thomas Jefferson University** · enrollment: 25 (actual)

## Conditions studied

- Breast Carcinoma

## Interventions

- **PROCEDURE:** Ultrasonsgraphy
- **DRUG:** Perflutren Lipid Microcpheres
- **PROCEDURE:** Contrast - Enhanced Ultrasound

## Key facts

- **NCT ID:** NCT04721886
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-24
- **Primary completion:** 2023-07-11
- **Final completion:** 2023-07-11
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2026-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04721886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04721886, "Contrast-Enhanced Ultrasound Scan for the Estimation of Tissue Pressure in Patients With Breast Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04721886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*